AAAAAA

   
Results: 1-16 |
Results: 16
RECIPROCAL CHANGES IN CIRCULATING INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR DURING EVOLVING SEPSIS IN LEUKOCYTOPENIC PATIENTS
Authors: OSTERMANN H KRATZALBERS K MESTERS RM KIEHL M KIENAST J
Citation: H. Ostermann et al., RECIPROCAL CHANGES IN CIRCULATING INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR DURING EVOLVING SEPSIS IN LEUKOCYTOPENIC PATIENTS, The Journal of infectious diseases, 176(3), 1997, pp. 825-828
COMPARATIVE-ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN CORONARY-ARTERIES FROM HUMAN HEART EXPLANTS
Authors: PADRO T STEINS M LI CX MESTERS RM HAMMEL D SCHELD HH KIENAST J
Citation: T. Padro et al., COMPARATIVE-ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN CORONARY-ARTERIES FROM HUMAN HEART EXPLANTS, Cardiovascular Research, 36(1), 1997, pp. 28-36
LOW-PROTEIN-C LEVELS PREDICT OUTCOME IN NEUTROPENIC PATIENTS WITH SEPSIS
Authors: MESTERS RM HARTMAN D YAN B KIENAST J
Citation: Rm. Mesters et al., LOW-PROTEIN-C LEVELS PREDICT OUTCOME IN NEUTROPENIC PATIENTS WITH SEPSIS, Blood, 90(10), 1997, pp. 3191-3191
ACTIVATION OF THE CONTACT SYSTEM IN PATIENTS WITH SEPSIS AND WITH SEPTIC SHOCK - RESPONSE
Authors: MESTERS RM CUGNO M MANNUCCI PM
Citation: Rm. Mesters et al., ACTIVATION OF THE CONTACT SYSTEM IN PATIENTS WITH SEPSIS AND WITH SEPTIC SHOCK - RESPONSE, Blood, 89(10), 1997, pp. 3894-3894
INCREASE OF PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS
Authors: MESTERS RM FLORKE N OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., INCREASE OF PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS, Thrombosis and haemostasis, 75(6), 1996, pp. 902-907
FACTOR VIIA AND ANTITHROMBIN-III ACTIVITY DURING SEVERE SEPSIS AND SEPTIC SHOCK IN NEUTROPENIC PATIENTS
Authors: MESTERS RM MANNUCCI PM COPPOLA R KELLER T OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., FACTOR VIIA AND ANTITHROMBIN-III ACTIVITY DURING SEVERE SEPSIS AND SEPTIC SHOCK IN NEUTROPENIC PATIENTS, Blood, 88(3), 1996, pp. 881-886
MARKERS OF COAGULATION ACTIVATION FOR EVALUATION OF THE ANTITHROMBOTIC EFFICACY OF HEPARIN - A PROSPECTIVE-STUDY IN ACUTE DEEP VENOUS THROMBOSIS
Authors: MESTERS RM MIKOTEIT T SCHILLER M KRINGS W OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., MARKERS OF COAGULATION ACTIVATION FOR EVALUATION OF THE ANTITHROMBOTIC EFFICACY OF HEPARIN - A PROSPECTIVE-STUDY IN ACUTE DEEP VENOUS THROMBOSIS, Blood coagulation & fibrinolysis, 6(7), 1995, pp. 665-671
MARKERS OF COAGULATION ACTIVATION AND TISSUE FACTOR PATHWAY INHIBITORFOR EVALUATION OF ANTITHROMBOTIC EFFICACY OF HEPARIN - A PROSPECTIVE-STUDY IN ACUTE DEEP-VEIN THROMBOSIS
Authors: MESTERS RM MIKOTEIT T SCHILLER M KIENAST J
Citation: Rm. Mesters et al., MARKERS OF COAGULATION ACTIVATION AND TISSUE FACTOR PATHWAY INHIBITORFOR EVALUATION OF ANTITHROMBOTIC EFFICACY OF HEPARIN - A PROSPECTIVE-STUDY IN ACUTE DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1101-1101
INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) ACTIVITY AT ONSET OF FEVER PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS
Authors: MESTERS RM FLORKE N OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) ACTIVITY AT ONSET OF FEVER PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1145-1145
HEMORRHAGIC DIATHESIS
Authors: MESTERS RM STENZINGER W
Citation: Rm. Mesters et W. Stenzinger, HEMORRHAGIC DIATHESIS, Der Internist, 36(1), 1995, pp. 77-90
CYTOKINE RESPONSE TO INFECTION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA FOLLOWING INTENSIVE CHEMOTHERAPY
Authors: OSTERMANN H ROTHENBURGER M MESTERS RM VANDELOO J KIENAST J
Citation: H. Ostermann et al., CYTOKINE RESPONSE TO INFECTION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA FOLLOWING INTENSIVE CHEMOTHERAPY, British Journal of Haematology, 88(2), 1994, pp. 332-337
INTERACTIONS AND INHIBITION OF BLOOD-COAGULATION FACTOR-VA INVOLVING RESIDUES 311-325 OF ACTIVATED PROTEIN-C
Authors: MESTERS RM HEEB MJ GRIFFIN JH
Citation: Rm. Mesters et al., INTERACTIONS AND INHIBITION OF BLOOD-COAGULATION FACTOR-VA INVOLVING RESIDUES 311-325 OF ACTIVATED PROTEIN-C, Protein science, 2(9), 1993, pp. 1482-1489
IDENTIFICATION OF A SEQUENCE IN THE LIGHT-CHAIN OF HUMAN ACTIVATED PROTEIN-C (RESIDUES-142-155) ESSENTIAL FOR ITS INTERACTION WITH FACTOR-VA
Authors: MESTERS RM GRIFFIN JH
Citation: Rm. Mesters et Jh. Griffin, IDENTIFICATION OF A SEQUENCE IN THE LIGHT-CHAIN OF HUMAN ACTIVATED PROTEIN-C (RESIDUES-142-155) ESSENTIAL FOR ITS INTERACTION WITH FACTOR-VA, Thrombosis and haemostasis, 69(6), 1993, pp. 722-722
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN SEPTICEMIA - A PROSPECTIVE-STUDY IN NEUTROPENIC PATIENTS
Authors: MESTERS RM KIENAST J OSTERMANN H VANDELOO J
Citation: Rm. Mesters et al., TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN SEPTICEMIA - A PROSPECTIVE-STUDY IN NEUTROPENIC PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1198-1198
CYTOKINE RELEASE DURING SEPSIS IN LEUKOCYTOPENIC PATIENTS - RESULTS OF A PROSPECTIVE-STUDY
Authors: OSTERMANN H ROTHENBURGER M MESTERS RM VANDELOO J KIENAST J
Citation: H. Ostermann et al., CYTOKINE RELEASE DURING SEPSIS IN LEUKOCYTOPENIC PATIENTS - RESULTS OF A PROSPECTIVE-STUDY, Blood, 82(10), 1993, pp. 10000253-10000253
A NOVEL EXOSITE IN THE LIGHT-CHAIN OF HUMAN ACTIVATED PROTEIN-C ESSENTIAL FOR INTERACTION WITH BLOOD-COAGULATION FACTOR VA
Authors: MESTERS RM HEEB MJ GRIFFIN JH
Citation: Rm. Mesters et al., A NOVEL EXOSITE IN THE LIGHT-CHAIN OF HUMAN ACTIVATED PROTEIN-C ESSENTIAL FOR INTERACTION WITH BLOOD-COAGULATION FACTOR VA, Biochemistry, 32(47), 1993, pp. 12656-12663
Risultati: 1-16 |